ABOUT US
An independent team connecting planning with distribution
We are an independent consultancy dedicated to pharmaceutical supply chains.
Restricted shipments, expired stock, temperature excursions and interrupted supplies of active pharmaceutical ingredients (APIs) cannot be resolved by one department alone.
We see demand, procurement, manufacturing, storage, delivery and pharmaceutical wholesalers (the distributors supplying pharmacies and healthcare providers) as one continuous chain, and work on both planning processes and operational records.

SUPPLY FLOW
- Companies supported
- 120+ companies
- Advisory clients
- 18 companies
- Employees
- 24 people
OUR EXPERTISE
One team across three areas of expertise

Planning and operations
Forecast accuracy, safety stock policies and monthly planning meetings.

Quality and distribution
Documentation under GDP (Good Distribution Practice, guidelines for medicine distribution quality), temperature records, shipment release and traceability.

Procurement and risk
Multiple sourcing of active pharmaceutical ingredients, contract manufacturer evaluation and alternatives when supply stops.
Keeping these three areas within one team is central to our approach.
CHALLENGES
Do these challenges sound familiar?

Next period's demand forecast is based almost entirely on the sales team's judgment.
We reveal changes in demand and inventory and examine gaps between plans and actual results.

Safety stock days have stayed unchanged for years, and nobody can explain the basis.
We review the basis for safety stock using demand variability and procurement lead times.

GDP procedures are documented, but warehouse operations have barely changed.
We review quality records and operations to establish procedures teams can maintain.

A second source of active pharmaceutical ingredients remains stuck in the internal approval process.
We map and prioritize risks from procurement through supply.

Nobody reviews the cost of returns and disposal each month.
We track returns and disposal monthly to identify causes and improvement priorities.
We examine each of these issues in the initial assessment.
ASSESSMENT
Start with a three-week assessment
In three weeks, we identify where to begin improving your supply chain.
Our Assessment page explains the scope, required documents, report contents and fees.
The assessment is a standalone engagement with no requirement for a follow-on contract.
CLIENTS
Who we support






From our founding through 2026, we have supported more than 120 companies, mainly pharmaceutical manufacturers, generic drug manufacturers, CDMOs (contract development and manufacturing organizations), pharmaceutical wholesalers, medical device manufacturers and dispensing pharmacy chains.
We currently have ongoing advisory agreements with 18 companies.
Given the nature of our engagements, we do not disclose client names.
NEXT ACTION
Where to go next
Our Services page outlines each service and its typical duration, while Case studies explains how engagements proceed and the results achieved.
If you are beginning internal discussions, we offer free resources covering supply risk checks.
Please request them through Seminars and resources.
